Lupin Pharmaceuticals, Inc. Announces Approval Of Ceftriaxone 10G Vials
BALTIMORE, Sept. 14 /PRNewswire/ -- Lupin Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted final approval for its Abbreviated New Drug Application (ANDA) for Ceftriaxone Injection 10 gram vials (Pharmacy bulk pack). Ceftriaxone is the generic equivalent of Rocephin® marketed by Roche.